Prosecution Insights
Last updated: April 19, 2026

Examiner: KALLAL, ROBERT JAMES

Tech Center 1600 • Art Units: 1671 1685

This examiner grants 59% of resolved cases

Performance Statistics

59.1%
Allow Rate
-0.9% vs TC avg
128
Total Applications
+32.3%
Interview Lift
1599
Avg Prosecution Days
Based on 88 resolved cases, 2023–2026

Rejection Statute Breakdown

23.5%
§101 Eligibility
9.3%
§102 Novelty
31.2%
§103 Obviousness
23.7%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17805138 SIGNAL-TO-NOISE-RATIO METRIC FOR DETERMINING NUCLEOTIDE-BASE CALLS AND BASE-CALL QUALITY Non-Final OA Illumina, Inc.
17687586 ARTIFICIAL INTELLIGENCE-BASED BASE CALLER WITH CONTEXTUAL AWARENESS Non-Final OA Illumina, Inc.
17691049 DETECTING THE PRESENCE OF A TUMOR BASED ON OFF-TARGET POLYNUCLEOTIDE SEQUENCING DATA Non-Final OA GUARDANT HEALTH, INC.
16626111 MHC-1 Genotype Restricts The Oncogenic Mutational Landscape Final Rejection The Regents of the University of California
19245981 SYSTEMS AND METHODS FOR DISTINGUISHING NUCLEIC ACIDS IN MIXED SAMPLES Final Rejection CareDx, Inc.
17354992 METHOD AND DEVICE FOR ASCERTAINING AN RNA SEQUENCE Non-Final OA Robert Bosch GmbH
16485623 METHOD AND SYSTEMS FOR THE RECONSTRUCTION OF GENOMIC REFERENCE SEQUENCES FROM COMPRESSED GENOMIC SEQUENCE READS Non-Final OA KONINKLIJKE PHILIPS N.V.
17123591 METHODS, SYSTEMS, AND RELATED COMPUTER PROGRAM PRODUCTS FOR EVALUATING CANCER MODEL FIDELITY Non-Final OA THE JOHNS HOPKINS UNIVERSITY
18189723 METHOD AND SYSTEM FOR SIZING A POPULATION OF NUCLEIC ACID FRAGMENTS USING A DIGITAL ASSAY Non-Final OA Bio-Rad Laboratories, Inc.
17365786 SYSTEMS AND METHODS FOR DETERMINING ANEUPLOIDY RISK USING SAMPLE FETAL FRACTION Final Rejection Natera, Inc.
17574921 SENSING OF BIOLOGICAL CELLS IN A SAMPLE FOR CELL TYPE IDENTIFICATION Final Rejection Sanofi
17594728 METHOD FOR QUICKLY IDENTIFYING CLEAN TRANSGENIC OR GENE-EDITED PLANTS AND INSERTION SITES BY USING WHOLE GENOME RE-SEQUENCING DATA Final Rejection ZHEJIANG UNIVERSITY
17252698 MEASUREMENT AND PREDICTION OF VIRUS GENETIC MUTATION PATTERNS Final Rejection The Chinese University of Hong Kong
17554690 System for Identifying Structures of Molecular Compounds from Mass Spectrometry Data Final Rejection Carnegie Mellon University
17773671 APPLICATION OF MOSAICISM RATIO IN MULTIFETAL GESTATIONS AND PERSONALIZED RISK ASSESSMENT Non-Final OA SEQUENOM, INC.
17855736 METHOD FOR ESTABLISHING ROBUST PREDICTION MODEL, PREDICTION SYSTEM, AND PROGNOSTIC SYSTEM FOR ALZHEIMER'S DISEASE Non-Final OA Kaohsiung Medical University
17440993 COMPUTERIZED SYSTEM AND METHOD FOR ANTIGEN-INDEPENDENT DE NOVO PREDICTION OF CANCER-ASSOCIATED TCR REPERTOIRE Non-Final OA Board of Regents of the University of Texas System
18170396 EPITOPE MIMICS Non-Final OA IOGENETICS, LLC
17626795 DATA PROCESSING METHOD AND SYSTEM USING AUTOTHRESHOLDING Non-Final OA GENCURIX INC.
17571840 SYSTEM AND METHOD FOR EVALUATING BIOLOGICAL DATA USING AND APPLYING A VIRTUAL LANDSCAPE Non-Final OA Accencio LLC
17817421 SOMATIC VARIANT COOCCURRENCE WITH ABNORMALLY METHYLATED FRAGMENTS Non-Final OA GRAIL, Inc.
16719938 CANCER TISSUE SOURCE OF ORIGIN PREDICTION WITH MULTI-TIER ANALYSIS OF SMALL VARIANTS IN CELL-FREE DNA SAMPLES Final Rejection GRAIL, Inc.
17596888 SYNTHETIC BIOLOGICAL CHARACTERISTIC GENERATOR BASED ON REAL BIOLOGICAL DATA SIGNATURES Final Rejection INSILICO MEDICINE IP LIMITED
17770580 METHOD FOR SCREENING IVF EMBRYOS Non-Final OA GenEmbryomics Pty. Ltd.
17711047 ANALYZING DEVICE, ANALYZING METHOD AND STORAGE MEDIUM STORING PROGRAM Non-Final OA Liquid Mine, Inc.
17656302 METHODS AND APPARATUS FOR GENERATING A VIRTUAL MODEL OF XENOBIOTIC EXPOSURE USING TRANSCRIPTOMICS ANALYSIS OF LIQUID BIOPSY SAMPLES Non-Final OA Certara USA, Inc.
17700728 Methods Circuits Devices Systems and Machine Executable Code for Glucose Event Detection Non-Final OA CaloSense Ltd.
17050799 METHODS OF DIAGNOSING DISEASE USING MICROFLOW CYTOMETRY Non-Final OA Nanostics Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month